What We're Reading: Page 320
Industry reads hand-picked by our editors
Dec 05, 2016
Dec 02, 2016
Dec 01, 2016
Nov 30, 2016
Nov 29, 2016
Nov 28, 2016
-
EP Vantage
Why J&J shouldn’t buy Actelion
-
The Wall Street Journal
Drugmakers find competition doesn’t keep a lid on prices
-
NPR
Patients increasingly influence the direction of medical research
-
Reuters
French cancer specialist Innate Pharma can remain independent, for now: CEO
-
The Washington Post
New tricks in canine cancer research may improve treatments for humans, too
Nov 23, 2016
-
Bloomberg Gadfly
Biotech should cash in its Trump bump
-
The Wall Street Journal
Fentanyl billionaire comes under fire as death toll mounts from prescription opioids
-
MIT Technology Review
Do your family members have a right to your genetic code?
Previous
